enow.com Web Search

  1. Ad

    related to: astrazeneca lung cancer products

Search results

  1. Results from the WOW.Com Content Network
  2. AstraZeneca's Imfinzi gets FDA priority review for type of ...

    www.aol.com/news/astrazenecas-imfinzi-gets-fda...

    AstraZeneca said Imfinzi was also recently granted Breakthrough Therapy Designation by the FDA in the same setting, which will help accelerate the regulatory review. Small cell lung cancer is a ...

  3. AstraZeneca's Imfinzi improves survival in late-stage lung ...

    www.aol.com/news/astrazenecas-imfinzi-shows...

    By Eva Mathews (Reuters) -AstraZeneca said on Friday its blockbuster cancer drug Imfinzi helped improve survival in patients in the early stages of an aggressive type of lung cancer, making it the ...

  4. US FDA approves AstraZeneca's non-small cell lung cancer ...

    www.aol.com/news/us-fda-approves-astrazenecas...

    (Reuters) - The U.S. Food and Drug Administration approved AstraZeneca's blockbuster cancer drug, Imfinzi, for the treatment of patients with a type of non-small cell lung cancer on Thursday.

  5. AstraZeneca's Investigational Cancer Drug Disappoints In Late ...

    www.aol.com/astrazenecas-investigational-cancer...

    At the World Conference on Lung Cancer (WCLC), the British pharma giant shared results from the NeoCOAST-2 Phase 2 platform trial of Imfinzi (durvalumab) in multiple combinations, before and after ...

  6. Durvalumab - Wikipedia

    en.wikipedia.org/wiki/Durvalumab

    Durvalumab, [8] sold under the brand name Imfinzi, is an FDA-approved immunotherapy for cancer, developed by Medimmune/AstraZeneca. [9] It is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 with the PD-1 (CD279).

  7. Savolitinib - Wikipedia

    en.wikipedia.org/wiki/Savolitinib

    It is being investigated for the treatment of cancer by AstraZeneca. [1] It is in phase II clinical trials for adenocarcinoma, non-small cell lung cancer, and renal cell carcinoma. [2] It has been given conditional approval for these indication in China. [3]

  8. AstraZeneca’s Imfinzi Trial Shows Survival In Lung Cancer ...

    www.aol.com/news/astrazeneca-imfinzi-trial-shows...

    AstraZeneca said that additional data from the Phase 3 trial of its Imfinzi treatment showed “unprecedented” survival in unresectable, Stage 3 cell lung cancer with an estimated 50% of ...

  9. Cediranib - Wikipedia

    en.wikipedia.org/wiki/Cediranib

    On February 27, 2008, AstraZeneca announced that the use of cediranib in non-small cell lung cancer will not progress into phase III after failing to meet its main goal. On 8 March 2010, AstraZeneca issued a press-release stating that cediranib had failed Phase III clinical trials for use in first-line metastatic colorectal cancer when it was ...

  1. Ad

    related to: astrazeneca lung cancer products